Clinical Trial Update: Ezetimibe in Patients Hypo-responsive to Statins [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating ezetimibe in statin-hyporesponsive patients with high cholesterol and coronary artery disease was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• High Cholesterol

Drugs mentioned

• EZETIMIBE (EZETIMIBE)

Snippet

Sponsor: University of California, San Diego | Conditions: High Cholesterol, Coronary Artery Disease | Phase 3 | Status: TERMINATED | Results posted: 2019-08-21